Insilico Medicine develops new AI drug discovery system
Insilico Medicine has developed an artificial intelligence (AI)-powered system to facilitate the creation of therapeutic...
Read More...
Focus:
Hong-kong
-
![Nefecon Greater China]()
Everest Medicines to commercialise Calliditas’ Nefecon in Greater China and Singapore
Sweden-based Calliditas Therapeutics has announced that Everest Medicines will commercialise its IgA nephropathy (IgAN) drug...
Read More...
-
![Roivant and Sinovant launch biopharma firm Cytovant Sciences]()
Roivant and Sinovant launch biopharma firm Cytovant Sciences
Global healthcare company Roivant Sciences and Chinese drugmaker Sinovant Sciences have launched a new biopharmaceutical...
Read More...
-
M&As this week: ProKidney, Quest Products, Gencore Pacific
ProKidney has acquired inRegen and its subsidiary Twin City Bio.
Read More...
-
![MabSpace Biosciences merger with HJB]()
MabSpace Biosciences merges with bioprocessing technology firm HJB
Hong Kong-based biotech company MabSpace Biosciences has signed a definitive agreement to merge with bioprocessing...
Read More...
-
Kite partners with HiFiBiO Therapeutics for TCR-based cancer therapies
Gilead Sciences’ subsidiary Kite has signed a research collaboration and licence agreement with biotechnology company...
Read More...
-
![robot to be used for drug delivery]()
Hong Kong researchers create tiny soft robot for drug delivery
Researchers at City University of Hong Kong have developed a tiny, soft robot that can...
Read More...
-
Alibaba to sell medical assets to Hong Kong unit for $1.35bn
Chinese conglomerate Alibaba Group is planning to sell certain healthcare assets under its Tmall Pharmacy...
Read More...
-
M&As this week: Datinvest, Shanghai Pharmaceuticals, Sunrise Bright Investment
Canadian company Datinvest International (Datinvest) has signed an agreement to purchase all the outstanding shares...
Read More...
-
M&As this week: Shenzhen Salubris Pharmaceuticals, USV, Sanofi
Chinese pharmaceutical company Shenzhen Salubris Pharmaceuticals has agreed to purchase a 10.81% stake in a...
Read More...
Go Top
